Browsing by Subject "Ruthenium"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Publication
    Open Access
    Kinetics and mechanistic insights into the acetate-assisted dimerization of terminal alkynes under ruthenium- and acid-promoted (RAP) catalysis
    (American Chemical Society, 2017-09-21) Salvio, Riccardo; Juliá Hernández, Francisco; Pisciottani, Luca; Mendoza-Meroño, Rafael; García-Granda, Santiago; Bassetti, Mauro; Química Inorgánica
    The mechanism of the dimerization of terminal aryl alkynes promoted by [{RuCl(μ-Cl)(η6-p-cymene)}2](1)/AcOH, under cooperative transition metal/Brønsted acid catalysis, has been investigated with regard to (i) the activation of the dinuclear ruthenium complex and (ii) the catalytic formation of the trans-1,4-diaryl-1,3-enyne products, by a detailed kinetic investigation of both processes. Complex 1 is subject to a slow solvolytic process in neat acetic acid or is transformed rapidly in the presence of sodium acetate to form the monomeric ruthenium(II) acetato complex [RuCl(η6-pcymene)(OAc)]. The latter is the active catalytic species promoting the alkyne dimerization process, via initial π-alkyne coordination and intramolecular C−H abstraction by the acetate ligand, as key steps of the catalytic cycle. The presence of additive acetate salts allows for the reaction to proceed at room temperature with short reaction times and high trans/cis stereoselectivity, thus rendering this catalytic system among the most active and selective procedures for the dimerization of terminal alkynes in a protic medium. The linear coupling of three molecules of phenylacetylene affords an organometallic ruthenium complex featuring a butenynyl ligand which has been characterized by X-ray crystallography.
  • Thumbnail Image
    Publication
    Open Access
    Synthesis and Characterization of New Ruthenium (II) Complexes of Stoichiometry [Ru(p-Cymene)Cl2L] and Their Cytotoxicity against HeLa-Type Cancer Cells
    (MDPI, 2022-10-26) Fuster, M. G.; Moulefera, I.; Montalbán, M. G.; Pérez, J.; Víllora Cano, Gloria; García, G.; Ingeniería Química; Facultad de Química
    When the [Ru(p-cymene)( -Cl)Cl]2 complex is made to react, in dichloromethane, with the following ligands: 2-aminobenzonitrile (2abn), 4-aminobenzonitrile (4abn), 2-aminopyridine (2ampy) and 4-aminopyridine (4ampy), after addition of hexane, the following compounds are obtained: [Ru(p-cymene)Cl2(2abn)] (I), [Ru(p-cymene)Cl2(4abn)] (II), [Ru(p-cymene)Cl2(2ampy] (III) and [Ru(pcymene) Cl2( -(4ampy)] (IV). All the compounds are characterized by elemental analysis of carbon, hydrogen and nitrogen, proton nuclear magnetic resonance, COSY 1H-1H, high-resolution mass spectrometry (ESI), thermogravimetry and single-crystal X-ray diffraction (the crystal structure of III is reported and compared with the closely related literature of II). The cytotoxicity effects of complexes were described for cervical cancer HeLa cells via 3-(4.5-dimethylthiazol-2-yl)-2.5-diphenyltetrazolium bromide (MTT) assay. The results demonstrate a low in vitro anticancer potential of the complexes.